November 08, 2018
A prominent cancer researcher failed to report conflicts of interest, receiving millions of dollars of payments from drug and health care companies, recently reported by The New York Times and ProPublica. Soon after, the scientist resigned. Associate Vice President for Research Integrity at the University of Utah, Jeffrey Botkin, M.D., discusses why the issue is problematic for research and researchers. Read more in Botkin’s Viewpoint published in JAMA.